We are live on
!
Find out more
Caption Management Portfolio holdings
AUM
$21.5B
Turnover
58.11%
1-Year Est. Return
81.81%
This Fund
S&P 500
This Quarter
Est. Return
-0.74%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$17.1B
AUM Growth
+$2.54B
(+17%)
Cap. Flow
-$40.7M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
2,194
New
682
Increased
333
Reduced
357
Closed
710
Avg Time Held Equity + Options
0.4
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blue Owl Capital
OWL
|
+$166M |
| 2 |
Meta Platforms (Facebook)
META
|
+$72.1M |
| 3 |
NVIDIA
NVDA
|
+$63.6M |
| 4 |
Take-Two Interactive
TTWO
|
+$56.8M |
| 5 |
Global X Cybersecurity ETF
BUG
|
+$23.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$128M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$124M |
| 3 |
Netflix
NFLX
|
+$48.3M |
| 4 |
Microsoft
MSFT
|
+$33M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 88.8% |
| 2 | Technology | 2.44% |
| 3 | Healthcare | 2.37% |
| 4 | Consumer Discretionary | 1.9% |
| 5 | Financials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
776
CALL
Claros Mortgage Trust
CMTG
$166M
| $2.38M | 0.01% |
1,000,000
| – | – |
2025 Q1
4 quarters
|
|
777
Zevra Therapeutics
ZVRA
$610M
| $2.38M | 0.01% |
255,236
-284,876
| -53% | -$2.57M |
2025 Q3
2 quarters
|
|
778
CALL
ARK Innovation ETF
ARKK
$8.92B
| $2.37M | 0.01% |
35,000
-4,100
| -10% | -$304K |
2025 Q3
2 quarters
|
|
779
CALL
Corvus Pharmaceuticals
CRVS
$829M
| $2.34M | 0.01% |
160,000
+135,000
| +540% | +$2.15M |
2025 Q4
1 quarter
|
|
780
CALL
Xeris Biopharma Holdings
XERS
$1.84B
| $2.34M | 0.01% |
403,400
+280,000
| +227% | +$1.86M |
2025 Q4
1 quarter
|
|
781
Herbalife
HLF
$1.53B
| $2.34M | 0.01% |
158,813
+114,113
| +255% | +$1.86M |
2025 Q3
2 quarters
|
|
782
CALL
CF Industries
CF
$18.1B
| $2.34M | 0.01% |
+18,000
| New | +$1.84M |
2026 Q1
0 quarters
|
|
783
CALL
Supernus Pharmaceuticals
SUPN
$2.3B
| $2.33M | 0.01% |
45,000
-12,700
| -22% | -$647K |
2025 Q4
1 quarter
|
|
784
PUT
Pagaya Technologies
PGY
$1.49B
| $2.32M | 0.01% |
+199,500
| New | +$3.15M |
2026 Q1
0 quarters
|
|
785
Vulcan Materials
VMC
$32.7B
| $2.31M | 0.01% |
+8,500
| New | +$2.5M |
2026 Q1
0 quarters
|
|
786
Ultragenyx Pharmaceutical
RARE
$1.5B
| $2.3M | 0.01% |
110,000
-109,500
| -50% | -$2.47M |
2024 Q3
6 quarters
|
|
787
Rocket Companies
RKT
$31.3B
| $2.28M | 0.01% |
+160,000
| New | +$2.91M |
2026 Q1
0 quarters
|
|
788
PUT
First Horizon
FHN
$10.8B
| $2.28M | 0.01% |
100,000
| – | – |
2025 Q3
2 quarters
|
|
789
Assembly Biosciences
ASMB
$419M
| $2.27M | 0.01% |
81,841
-24,750
| -23% | -$706K |
2025 Q4
1 quarter
|
|
790
CALL
Carlyle Group
CG
$13.1B
| $2.25M | 0.01% |
+46,600
| New | +$2.57M |
2026 Q1
0 quarters
|
|
791
Terrestrial Energy Warrant
IMSRW
$9.54M
| $2.24M | 0.01% |
865,372
+58,829
| +7% | +$221K |
2025 Q4
1 quarter
|
|
792
Scorpio Tankers
STNG
$4.15B
| $2.24M | 0.01% |
30,000
+11,140
| +59% | +$747K |
2025 Q3
2 quarters
|
|
793
CALL
Zeta Global
ZETA
$8.42B
| $2.23M | 0.01% |
+140,000
| New | +$2.59M |
2026 Q1
0 quarters
|
|
794
Novo Nordisk
NVO
$173B
| $2.23M | 0.01% |
60,600
-19,571
| -24% | -$927K |
2025 Q4
1 quarter
|
|
795
CALL
Alumis Inc
ALMS
$817M
| $2.2M | 0.01% |
+100,000
| New | +$2.5M |
2026 Q1
0 quarters
|
|
796
Caesars Entertainment
CZR
$5.96B
| $2.2M | 0.01% |
83,139
+67,203
| +422% | +$1.6M |
2025 Q3
2 quarters
|
|
797
CALL
Nutrien
NTR
$33.2B
| $2.2M | 0.01% |
+29,100
| New | +$2.08M |
2026 Q1
0 quarters
|
|
798
PUT
Bank of America
BAC
$362B
| $2.19M | 0.01% |
45,000
+10,000
| +29% | +$516K |
2025 Q4
1 quarter
|
|
799
Amer Sports
AS
$17.4B
| $2.19M | 0.01% |
+66,500
| New | +$2.43M |
2026 Q1
0 quarters
|
|
800
PUT
Onterris Inc
ONT
$494M
| $2.19M | 0.01% |
100,000
+97,500
| +3,900% | +$2.34M |
2024 Q4
5 quarters
|
|
Similar funds
Caption Management's Q1 2026 Portfolio in Review
As of Q1 2026, Caption Management held 2,194 positions worth $17.1B, up 17% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Caption Management's Q1 2026 filing shows 682 new, 333 increased, 357 reduced and 710 closed positions. Its largest new stake was Meta Platforms (Facebook): 112,500 shares worth $64.4M. The largest sale was Apple, an estimated $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 85% a quarter earlier, followed by Technology and Healthcare.
- Caption Management's largest Q1 2026 buy was Meta Platforms (Facebook): 112,500 shares worth $64.4M.
- Caption Management added most to Blue Owl Capital in Q1 2026, an estimated $166M increase.
- Caption Management's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $124M.
- Caption Management fully exited Apple in Q1 2026, selling an estimated $128M.
- Caption Management's ten largest holdings make up 22% of its $17.1B portfolio in Q1 2026.
- Caption Management opened 682 new positions and closed 710 in Q1 2026.
- Caption Management's portfolio value rose 17% quarter-over-quarter to $17.1B.
Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.